Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | tissue type plasminogen activator | 0.1104 | 0.8048 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.1104 | 0.8048 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0691 | 0.1785 | 0.1785 |
Schistosoma mansoni | hypothetical protein | 0.109 | 0.7831 | 0.9673 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1104 | 0.8048 | 0.5 |
Brugia malayi | Kringle domain containing protein | 0.1104 | 0.8048 | 0.8048 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.109 | 0.7831 | 0.7831 |
Onchocerca volvulus | 0.1104 | 0.8048 | 0.8048 | |
Onchocerca volvulus | 0.1233 | 1 | 1 | |
Onchocerca volvulus | 0.109 | 0.7831 | 0.7831 | |
Toxoplasma gondii | kringle domain-containing protein | 0.1104 | 0.8048 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.1104 | 0.8048 | 0.5 |
Onchocerca volvulus | 0.109 | 0.7831 | 0.7831 | |
Schistosoma mansoni | hypothetical protein | 0.1104 | 0.8048 | 1 |
Onchocerca volvulus | 0.109 | 0.7831 | 0.7831 | |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.1104 | 0.8048 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1104 | 0.8048 | 0.8048 |
Brugia malayi | SEA domain containing protein | 0.109 | 0.7831 | 0.7831 |
Loa Loa (eye worm) | hypothetical protein | 0.1233 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.109 | 0.7831 | 0.7831 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.1104 | 0.8048 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.1104 | 0.8048 | 0.8048 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.1104 | 0.8048 | 0.8048 |
Onchocerca volvulus | 0.109 | 0.7831 | 0.7831 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.